Genedx

Genedx company information, Employees & Contact Information

Explore related pages

Related company profiles:

We see a world where every genetic condition is understood, and every patient receives the care their need to live their fullest life. Our approach to genetic testing, along with having one of the world's most diverse rare disease data sets, makes us a catalyst for clear, connected and actionable care. Named one of Fast Company's Most Innovative Companies of 2025, we're leading the way to a future where we end the diagnostic odyssey. It all begins with a single test.

Company Details

Employees
942
Address
333 Ludlow Street, 8th Floor,united States
Phone
+1 301-519-2100
Email
ze****@****edx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
genedx.com
HQ
Stamford, CT
Looking for a particular Genedx employee's phone or email?

Genedx Questions

News

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights - Yahoo Finance

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights Yahoo Finance

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025 - Business Wire

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025 Business Wire

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing - FinancialContent

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing FinancialContent

Genomics Leader GeneDx Sets Q2 2025 Earnings Release Date: Key Financial Results Coming July 29 - Stock Titan

Genomics Leader GeneDx Sets Q2 2025 Earnings Release Date: Key Financial Results Coming July 29 Stock Titan

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program - Yahoo Finance

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program Yahoo Finance

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Business Wire

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 Business Wire

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors - Yahoo Finance

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors Yahoo Finance

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting - Business Wire

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting Business Wire

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer - Business Wire

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer Business Wire

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies Yahoo Finance

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program - Business Wire

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program Business Wire

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award - Business Wire

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award Business Wire

GeneDx to Participate in Upcoming Investor Conferences - Business Wire

GeneDx to Participate in Upcoming Investor Conferences Business Wire

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth - Business Wire

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth Business Wire

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference - Business Wire

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference Business Wire

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights Business Wire

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights Business Wire

GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire

GeneDx Announces Completion of Fabric Genomics Acquisition Business Wire

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale - Business Wire

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale Business Wire

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis - Business Wire

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis Business Wire

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment - Business Wire

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment Business Wire

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients - Business Wire

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients Business Wire

GeneDx to Acquire Fabric Genomics - citybiz

GeneDx to Acquire Fabric Genomics citybiz

GeneDx Announces Preliminary 2024 Financial Results - Business Wire

GeneDx Announces Preliminary 2024 Financial Results Business Wire

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer - Business Wire

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer Business Wire

GeneDx to Present at Piper Sandler Healthcare Conference, Showcasing Genomic Solutions - Stock Titan

GeneDx to Present at Piper Sandler Healthcare Conference, Showcasing Genomic Solutions Stock Titan

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients - Business Wire

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients Business Wire

Stamford’s GeneDx launches program to expand genetic testing for pediatric epilepsy patients - Hartford Business Journal

Stamford’s GeneDx launches program to expand genetic testing for pediatric epilepsy patients Hartford Business Journal

Whole Genome Sequencing - Genetic Engineering and Biotechnology News

Whole Genome Sequencing Genetic Engineering and Biotechnology News

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option - Yahoo Finance

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option Yahoo Finance

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform - OPKO Health, Inc.

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform OPKO Health, Inc.

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes - PR Newswire

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes PR Newswire

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services - OPKO Health, Inc.

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services OPKO Health, Inc.

OPKO Health Appoints Katherine Stueland as CEO of GeneDx - citybiz

OPKO Health Appoints Katherine Stueland as CEO of GeneDx citybiz

OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio - PR Newswire

OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio PR Newswire

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 - FinancialContent

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 FinancialContent

Top Genedx Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant